|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Service revenue | |||
| Direct center and patient care costs | |||
| Other regional and center support costs | |||
| Depreciation | |||
| Cost of revenue | |||
| Regional operating loss | |||
| Corporate, general and administrative expenses | |||
| Share-based compensation | |||
| Amortization | |||
| Loss on extinguishment of loans | |||
| Forgiveness of loan payable | |||
| Impairment loss | |||
| Basic | |||
| Non-controlling interest | |||
| Common shareholders of Greenbrook TMS | |||
| Revenue: | |||
| Service revenue | |||
| Expenses: | |||
| Direct center and patient care costs | |||
| Other regional and center support costs (note 25) | |||
| Depreciation (notes 6 and 8(a)) | |||
| Total | |||
| Regional operating income (loss) | |||
| Center development costs | |||
| Corporate, general and administrative expenses (note 25) | |||
| Share-based compensation (note 16) | |||
| Amortization (note 7 (a)) | |||
| Interest expense | |||
| Interest income | |||
| Loss on extinguishment of loans (note 10(a)(ii)) | |||
| Loss on settlements (note 12(d) and 12(e)) | |||
| Impairment loss (note 7(b), note 7(c) and note 8(b)) | |||
| Loss before income taxes | |||
| Income tax expense (note 19) | |||
| Loss for the year and comprehensive loss | |||
| Non-controlling interest (note 24) | |||
| Loss for the year and comprehensive loss attributable to Greenbrook | |||
| Net loss per share (note 23): | |||
| Basic | |||
| Diluted |
Loading...
